Alpha-9 Oncology
Manufacturing · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
185 Dartmouth St Ste 6, Boston, Massachu...Phone Number
(617) 865-1004Website
www.a9oncology.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About Alpha-9 Oncology
Alpha-9 Oncology is a clinical-stage radiopharmaceutical company specializing in the development of highly selective and potent radiopharmaceuticals for cancer therapy. The company employs a bespoke, iterative design process to create targeted molecules that treat cancer cells with precision. With a leadership team experienced in oncology drug development, Alpha-9 is backed by top-tier investors and is committed to advancing cancer care through innovative precision medicine. Their portfolio includes advanced radiotherapeutics, such as A9-3408, which is currently in Phase 1 studies.Explore more
Alpha-9 Oncology Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Alpha-9 Oncology your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Alpha-9 Oncology is spiking on competitors!
Click to see if Alpha-9 Oncology had a recent Job posting/layoffs
Earning: See what the market has to say on Alpha-9 Oncology recently announced quarterly report
Product Launch: Get notified when Alpha-9 Oncology launches new products
Website visits: Recent activity has been detected on your website
Check if Alpha-9 Oncology has recently received funding, and reach out quickly before it becomes old news!
Alpha-9 Oncology, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Alpha-9 Oncology has new funding data
Congratulate Masked Content for being promoted to Masked Content at Alpha-9 Oncology
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined Alpha-9 Oncology as Masked Content
Find 3 more new buyers
Compare Similar Companies to Alpha-9 Oncology
Compare insights from companies similar to Alpha-9 Oncology, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Alpha-9 Oncology is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Alpha-9 Oncology is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Alpha-9 Oncology.
Alpha-9 Oncology financials insights
Gather financial insights about Alpha-9 Oncology, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Series C
$175M
Alpha-9 Oncology Tech Stack
A closer look at the technologies used by Alpha-9 Oncology
See more technologies
Most Recent Scoops
Open Position
Open Position
Open Position
Open Position
New Hire
Executive Move
Executive Moves, New Hire
Alpha-9 Oncology News & Media
Alpha-9 Oncology Appoints Paul Blanchfield as Chief Executive Officer - PR Newswire
/PRNewswire/ -- Alpha-9 Oncology ("Alpha-9" or "the Company"), a clinical-stage radiopharmaceutical company developing targeted cancer therapies, today...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Alpha-9 Oncology
Sign Up For FreeTo access detailed company insights
Alpha-9 Oncology is a clinical-stage radiopharmaceutical company specializing in the development of highly selective and potent radiopharmaceuticals for cancer therapy. The company employs a bespoke, iterative design process to create targeted molecules that treat cancer cells with precision. With a leadership team experienced in oncology drug deve... Read More
